Connect with us
Aortyx has received a $2.8 million (€2.5 million) grant from the European Commission. Prior to this investment, the company was already recognized and funded with more...
The negative variation of the Spanish pharmaceutical sector contrasts with the positive performance of the Ibex35, which recorded a rise of 8% at the close of...
The Spanish multinational Grifols, specialized in the production of blood products, has continued to expand its network with the launch of the first integrated plasma supply...
Moira Capital, based in Madrid, started its activity in early 2017 as a manager specialized in direct high-return investments for private investors and institutions. The company...
Currently the company Psious, according to the data provided, has more than 2,000 therapist clients, has treated more than 16,000 patients, has conducted more than 150,000...
Endolipid Therapeutics has developed a peptide platform. With this round, the company aims to cover development costs during 2022 to reach two milestones: licensing the anti-cellulite...
HempFusion’s management team walks us through the evolving health and wellness market. As a company positioned to expand beyond their base business to take advantage of...
One company is aiming to unleash the potential of the psychedelic molecule LSD by commercially developing and testing a non-hallucinogenic variety (2-bromo-LSD) to treat a number...
the company is committing a $113 million (€100 million) plan to expand its Provencal manufacturing facility by another 4,000 square meters. This expansion, will almost double...
Extremadura has divided the execution of the contract into four annual payments. Two of these correspond to six months of 2021 and 2024, respectively, and the...
 |
|
 |  |
 |
|